Mulling It Over 100% FDI allowed in pharma sector through automatic route Seven top Indian firms have been acquired by MNCs in the past six years Fear of price rise in generic medicines if MNCs control market Health, commerce ministries want FDI to go through approvals PMO meeting key ministries next month to take a decision *** Prime Minister Manmohan Singh has always been firm in reminding domestic industry that their fear...
More »SEARCH RESULT
India’s drug ‘lifeline’ under threat by Mari Marcel Thekaekara
I never dreamed I’d ever wave the flag for Indian pharmaceutical companies. But some years ago, I discovered that India provides essential drugs to most of the world’s economically deprived nations. Many of the poorest people in India and Africa could not afford basic drugs if it were not for Indian drug companies. Astonishingly, India is known as the ‘pharmacy to the developing world’ and is something of a hero in...
More »"BRICS Can Ensure Affordable Drugs" by Ranjit Devraj
While ‘data exclusivity’ clauses will not feature in the India-European Union free trade agreement (FTA), the threat posed by the impending deal to the world’s supply of cheap generic drugs is far from over. India’s commerce and industry minister Anand Sharma assured Michel Sidibe, chief of the United Nations joint programme on HIV and AIDS (UNAIDS) at a meeting this week that India would reject attempts by pharmaceutical giants to include...
More »India seeks Poland's help for removal of EU trade curbs
-PTI India today sought help from Poland, which holds the European Union Presidency, for resolving trade obstacles for Indian agri exports to 27 EU countries. The issue was taken up at a meeting here between Commerce and Industry Minister Anand Sharma and visiting Polish Foreign Minister Radoslaw Sikorski. "The EU can play an important role in resolving several of our market access issues with the EU including in respect of arbitrary SPS (Sanitary...
More »Human Smears by Madhavi Tata
Poor Andhra villagers now victims of clinical drug trials No Drug Resistance * 35 women, some men from Guntur district put throughclinical trials of a breast cancer drug. They later complain of joint pains, nausea and chest pains. * Biotech industry in Andhra is worth about Rs 455 crore * Touts operating on behalf of pharma companies get people from the poorer districts to Hyderabad for the tests *** Some 35 women...
More »